Details of the Drug Formulations

General Information of Drug (ID: DMFI8A7)

Drug Name
Tranexamic Acid Drug Info
Synonyms
AMCA; AMCHA; AMH; Amikapron; Amstat; Anvitoff; Carxamin; Cyclocapron; Cyklokapron; Emorhalt; Exacyl; Frenolyse; Hexapromin; Hexatron; Mastop; Rikavarin; Spiramin; Tamcha; Tranex; Tranexamsaeure; Tranexan; Transamin; Transamlon; Trasamlon; Ugurol; Acide tranexamique; Acido tranexamico; Acidum tranexamicum; Tranexmic acid; Tranhexamic acid; Trans AMCHA; CL 65336; DV 79; DV79; KABI 2161; LT00159441; ALBB-006013; Acide tranexamique [INN-French]; Acido tranexamico [INN-Spanish]; Acidum tranexamicum [INN-Latin]; CL-65336; Cis-AMCHA; Cyklokapron (TN); DV-79; RP 18,429; Rikavarin (TN); Rikavarin-S; T-AMCHA; Tranexamic acid cis-form; Trans-Amcha; Trans-Tranexamic acid; Cis-4-(Aminomethyl)cyclohexanecarboxylic acid; Tranexamic acid (JP15/USAN/INN); Tranexamic acid [USAN:INN:BAN:JAN]; Trans-4-(Aminomethyl)cyclohexanecarboxylic acid; Trans-4-(Aminomethyl)cyclohexanecarboxylic acid ester; Trans-p-(Aminomethyl)cyclohexanecarboxylic; Trans-p-(Aminomethyl)cyclohexanecarboxylic acid; Cis-4-Aminomethylcyclohexane-1-carboxylic acid; Trans-1-Aminomethylcyclohexane-4-carboxylic acid; Trans-4-(Aminomethyl)cyclohexane-carboxylic acid; Trans-4-Aminomethylcyclohexane-1-carboxylic acid; Trans-1-(Aminomethyl)cyclohexane-4-carboxylic acid; Trans-4-(Aminomethyl)-1-cyclohexanecarboxylic acid; Trans-4-(Aminomethyl)cyclohexane-1-carboxylic acid; 4-(Aminomethyl)-Cyclohexanecarboxylic Acid; 4-(Aminomethyl)cyclohexanecarboxylic acid; 4-(aminomethyl)cyclohexane-1-carboxylic acid
Indication
Disease Entry ICD 11 Status REF
Excessive bleeding GA30.02 Approved [1]
Menorrhagia GA20.50 Approved [2]
Coronavirus Disease 2019 (COVID-19) 1D6Y Phase 2 [3]
Endometriosis GA10 Investigative [2]
Therapeutic Class
Antifibrinolytic Agents
Cross-matching ID
PubChem CID
5526
ChEBI ID
CHEBI:48669
CAS Number
701-54-2
TTD ID
D05HXX
ACDINA ID
D00696

Full List of Drug Formulations Containing This Drug

Tranexamic acid 650 mg tablet
Company Formulation ID FDA Description
Amring Pharmaceuticals F21585 Stearic acid; Lactose, unspecified form; Magnesium stearate; Silicon dioxide; Hypromelloses; Povidones; Starch, corn
Ferring Pharmaceuticals; Prasco F21583 Stearic acid; Magnesium stearate; Silicon dioxide; Cellulose, microcrystalline; Hypromelloses; Povidones; Starch, corn
Ferring Pharmaceuticals F21586 Stearic acid; Magnesium stearate; Silicon dioxide; Hypromellose, unspecified; Microcrystalline cellulose; Povidone, unspecified; Starch, corn
Actavis Pharma F21587 Lactose monohydrate; Glyceryl dibehenate; Magnesium stearate; Talc; Triethyl citrate; Crospovidone; Silicon dioxide; Cellulose, microcrystalline; Copovidone; Dimethylaminoethyl methacrylate - butyl methacrylate - methyl methacrylate copolymer; Hypromellose, unspecified; Polyethylene glycols
American Health Packaging F21588 Lactose monohydrate; Glyceryl dibehenate; Magnesium stearate; Talc; Triethyl citrate; Crospovidone; Silicon dioxide; Cellulose, microcrystalline; Copovidone k25-31; Dimethylaminoethyl methacrylate - butyl methacrylate - methyl methacrylate copolymer; Hypromelloses; Polyethylene glycols
Apotex; Golden State Medical Supply F21584 Magnesium stearate; Croscarmellose sodium; Silicon dioxide; Ethylcelluloses
------------------------------------------------------------------------------------
⏷ Show the Full List of 6 Formulation(s)

References

1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6573).
2 Tranexamic acid FDA Label
3 Tranexamic Acid (TXA) and Corona Virus 2019 (COVID19) in Inpatients (TCInpatient)